Yahoo! Finance: Drugs - Generic Industry News

Watson to Present at Credit Suisse Healthcare Conference (PR Newswire)

Fri, 6 Nov 2009 21:00:00 Etc/GMT

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Credit Suisse 18th Annual Healthcare Conference on Wednesday, November 11, 2009 at 12:00 pm Eastern Standard Time.

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution (PR Newswire)

Fri, 6 Nov 2009 15:36:00 Etc/GMT

Caraco Pharmaceutical Laboratories, Ltd. has launched ketorolac tromethamine ophthalmic solution, 0.5% following a final approval from the US Food and Drug Administration for Sun Pharma's Abbreviated New Drug Application for generic Acular® ophthalmic solution on the first day following patent expiration.

Par 3Q profit surges on product sales (AP)

Fri, 6 Nov 2009 14:49:05 Etc/GMT

Generic drugmaker Par Pharmaceutical Companies Inc. said Friday its profit surged in the third quarter on a boost in product sales.

Specialty Pharma Stock Picks From David Amsellem Of Piper Jaffray (Wall Street Transcript)

Fri, 6 Nov 2009 13:30:00 Etc/GMT

67 WALL STREET, New York - November 6, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009 (PR Newswire)

Fri, 6 Nov 2009 12:30:00 Etc/GMT

Par Pharmaceutical Companies, Inc. today reported results for the third quarter ended October 3, 2009.

Abraxis opens expanded plant in Phoenix, expected to create 200 jobs (at bizjournals.com)

Thu, 5 Nov 2009 17:05:22 Etc/GMT

Chinese Companies Traded On US Stock Exchanges Provide Deep Value For Investors According To First Wilshire Securities (Wall Street Transcript)

Thu, 5 Nov 2009 13:54:00 Etc/GMT

Watson Pharmaceuticals Q3 2009 Earnings Call Transcript (at Seeking Alpha)

Wed, 4 Nov 2009 20:22:09 Etc/GMT

Teva Reports Strong Quarter (Zacks.com)

Wed, 4 Nov 2009 20:03:35 Etc/GMT

Strong sales of Copaxone and in the respiratory business helped drive earnings in the reported quarter.

Pro-Pharmaceuticals Closes $310,000 Tranche; Brings Total to $4.1 Million of $6.0 Million Private Placement (Business Wire)

Wed, 4 Nov 2009 16:03:00 Etc/GMT

NEWTON, Mass.----Pro-Pharmaceuticals, Inc. , today announced that it has closed a $310,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants.

Watson 3Q profit falls 11 percent on taxes, costs (AP)

Wed, 4 Nov 2009 14:50:30 Etc/GMT

Drug developer Watson Pharmaceuticals Inc. said Wednesday its profit fell 11 percent in the third quarter as higher taxes and charges offset a revenue boost.

Watson Pharmaceuticals posts lower profit (at MarketWatch)

Wed, 4 Nov 2009 12:47:42 Etc/GMT

Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66 (PR Newswire)

Wed, 4 Nov 2009 12:30:00 Etc/GMT

[$$] Mylan Again Sues Pittsburgh Post-Gazette (at The Wall Street Journal Online)

Fri, 30 Oct 2009 23:07:05 Etc/GMT

Hi-Tech Pharmacal to Present at the 20th Annual Oppenheimer Healthcare Conference (Business Wire)

Fri, 30 Oct 2009 19:24:00 Etc/GMT

AMITYVILLE, N.Y.----Hi-Tech Pharmacal Co., Inc. today announced that it is scheduled to make an investor presentation at the 20th Annual Oppenheimer Healthcare Conference. David Seltzer, President and Chief Executive Officer, will deliver the Company's presentation on Tuesday, November 3, 2009, at 3:55 p.m.

Watson Pharmaceuticals names Joyce CFO (at MarketWatch)

Fri, 30 Oct 2009 11:55:32 Etc/GMT

Watson Names R. Todd Joyce Senior Vice President and Chief Financial Officer; Succeeds Mark W. Durand (PR Newswire)

Fri, 30 Oct 2009 11:30:00 Etc/GMT

Watson Pharmaceuticals today announced that R. Todd Joyce has been named Senior Vice President and Chief Financial Officer effective immediately.

Mylan Beats, Raises Outlook (Zacks.com)

Thu, 29 Oct 2009 18:56:38 Etc/GMT

Mylan reports 3Q loss on revenue drop, charge (AP)

Thu, 29 Oct 2009 12:18:04 Etc/GMT

Generic drugmaker Mylan Inc. said Thursday it posted a loss during the third quarter on a mix of lower revenue and costs for a legal settlement.

Mylan Laboratories swings to loss, raises outlook (at MarketWatch)

Thu, 29 Oct 2009 11:04:19 Etc/GMT